标题
Angiogenesis: A Target in Solid Tumors, Also in Leukemia?
作者
关键词
-
出版物
Hematology-American Society of Hematology Education Program
Volume 2011, Issue 1, Pages 1-8
出版商
American Society of Hematology
发表日期
2011-12-08
DOI
10.1182/asheducation-2011.1.1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PlGF
- (2011) Charlotte Rolny et al. CANCER CELL
- Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia
- (2011) Thomas Schmidt et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Bevacizumab potentiates chemotherapeutic effect on T-leukemia/lymphoma cells by direct action on tumor endothelial cells
- (2011) L. Wang et al. HAEMATOLOGICA
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Antiangiogenic therapy: impact on invasion, disease progression and metastasis
- (2011) John M. L. Ebos et al. Nature Reviews Clinical Oncology
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Leukemia regression by vascular disruption and antiangiogenic therapy
- (2010) G. J. Madlambayan et al. BLOOD
- Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease
- (2010) Sara Van de Veire et al. CELL
- Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
- (2010) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival
- (2010) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206
- (2010) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Disease Course Patterns After Discontinuation of Bevacizumab: Pooled Analysis of Randomized Phase III Trials
- (2010) David Miles et al. JOURNAL OF CLINICAL ONCOLOGY
- The leukemic stem cell niche: current concepts and therapeutic opportunities
- (2009) S. W. Lane et al. BLOOD
- Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization
- (2009) Massimiliano Mazzone et al. CELL
- Engraftment and Reconstitution of Hematopoiesis Is Dependent on VEGFR2-Mediated Regeneration of Sinusoidal Endothelial Cells
- (2009) Andrea T. Hooper et al. Cell Stem Cell
- "Antimyeloangiogenic" Therapy for Cancer by Inhibiting PlGF
- (2009) S. Loges et al. CLINICAL CANCER RESEARCH
- Regulation of Angiogenesis by Oxygen and Metabolism
- (2009) Peter Fraisl et al. DEVELOPMENTAL CELL
- Therapeutic targeting of microenvironmental interactions in leukemia: Mechanisms and approaches
- (2009) Marina Konopleva et al. DRUG RESISTANCE UPDATES
- Contribution of bone microenvironment to leukemogenesis and leukemia progression
- (2009) F Ayala et al. LEUKEMIA
- Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF
- (2009) Rossana Maffei et al. LEUKEMIA RESEARCH
- Imatinib and beyond—exploring the full potential of targeted therapy for CML
- (2009) Alfonso Quintás-Cardama et al. Nature Reviews Clinical Oncology
- FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme
- (2009) M. H. Cohen et al. ONCOLOGIST
- Role and Therapeutic Potential of VEGF in the Nervous System
- (2009) Carmen Ruiz de Almodovar et al. PHYSIOLOGICAL REVIEWS
- Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses
- (2009) Mitsuhiro Nakamura et al. VIROLOGY
- Soluble tissue factor has unique angiogenic activities that selectively promote migration and differentiation but not proliferation of endothelial cells
- (2008) Yingbo He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Translation of the Philadelphia chromosome into therapy for CML
- (2008) B. J. Druker BLOOD
- Antiangiogenesis in haematological malignancies
- (2008) William W. Li et al. BRITISH JOURNAL OF HAEMATOLOGY
- Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Thalidomide Plus Dexamethasone Compared With Dexamethasone As Initial Therapy for Newly Diagnosed Multiple Myeloma
- (2008) S. Vincent Rajkumar et al. JOURNAL OF CLINICAL ONCOLOGY
- Novel Aspects of Glutamatergic Signalling in the Neuroendocrine System
- (2008) E. Hrabovszky et al. JOURNAL OF NEUROENDOCRINOLOGY
- Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors
- (2008) H F S Negaard et al. LEUKEMIA
- Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib
- (2008) T. P. Padera et al. MOLECULAR CANCER THERAPEUTICS
- Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches
- (2008) Anita Sapoznikov et al. NATURE IMMUNOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia
- (2008) A. G. Zhelyazkova et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now